Viral Infection clinical trials

Explore recruiting viral infection clinical trials.

Recruiting viral infection studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Viral Infection trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Treatment of chemo-refractory viral infections after allogeneic stem cell transplantation with multispecific T cells against CMV, EBV and AdV: A phase III, prospective, multicentre clinical trial (TRACE)

Belgium, Germany, Italy, France, Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

Virus-specific T-cell Immunity for the Treatment of Some Resistant Viral Infections After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Italy

Human Pharmacology (Phase I)- Other EU CTIS Study details

Evaluation and promotion of specific adaptative immunity against polyomavirus (BKV) to prevent viral infection after kidney transplantation (BK-VAX project)

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Benefits of early discontinuation of antibiotic therapy versus standard management in elderly patients hospitalized for viral infection: a multicenter, open-label, cluster-randomized controlled study

France

Phase III and phase IV (Integrated) EU CTIS Study details

Randomized Open Label Trial Evaluating Efficacy and Safety of Intravenous Immunoglobulin (IVIg, Privigen) as Add-on to SoC Versus SoC Alone for Coronavirus Disease 2019 (COVID-19) in Patients with Severely Impaired B-cell Function

Sweden

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial to investigate the efficacy and safety of daxdilimab subcutaneous injection in reducing disease activity in adult participants with moderate-to-severe primary discoid lupus erythematosus.

Denmark, France, Czechia, Germany, Poland, Greece +1 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Viral Infection trials by city

Viral Infection in Toronto Viral Infection in Vancouver Viral Infection in Montreal Viral Infection in Calgary Viral Infection in Edmonton Viral Infection in Ottawa Viral Infection in Winnipeg Viral Infection in Quebec City Viral Infection in Hamilton Viral Infection in Kitchener Viral Infection in London Viral Infection in Halifax Viral Infection in New York Viral Infection in Los Angeles Viral Infection in Chicago Viral Infection in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease